title: Safety assessment of OTC drugs: doxylamine succinate.
authors.affiliation: Procter & Gamble Company, Cincinnati, OH 45242, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Skare
authors.forename: V A
authors.initials: VA
authors.lastname: Murphy
authors.forename: R C
authors.initials: RC
authors.lastname: Bookstaff
authors.forename: G A
authors.initials: GA
authors.lastname: Thompson
authors.forename: M A
authors.initials: MA
authors.lastname: Heise
authors.forename: Z D
authors.initials: ZD
authors.lastname: Horowitz
authors.forename: J H
authors.initials: JH
authors.lastname: Powell
authors.forename: A
authors.initials: A
authors.lastname: Parkinson
authors.forename: J V
authors.initials: JV
authors.lastname: St Peter
mesh_terms: D000818:Animals; D004319:Doxylamine / Q000031:analogs & derivatives* / Q000633:toxicity; D006634:Histamine H1 Antagonists / Q000633:toxicity*; D006801:Humans; D051379:Mice; D009153:Mutagens / Q000633:toxicity; D004366:Nonprescription Drugs / Q000633:toxicity*; D051381:Rats
chemical_list: D006634:Histamine H1 Antagonists; D009153:Mutagens; D004366:Nonprescription Drugs; D004319:Doxylamine; C035385:doxylamine succinate